Medicine
New hydrogel can repair tears in human tissue
Research
EPFL
EPFL scientists have developed an injectable gel that can attach to various kinds of soft internal tissues and repair tears resulting from an accident or trauma. 
Parkinson's disease: wearable sensors to track symptoms
TechTransfer
EPFL
EPFL scientists have developed algorithms that, combined with wearable sensors, could help clinicians to monitor the progression of Parkinson’s disease and assess the effects of medications commonly used by people with this neurodegenerative disorder.
Urolithin A shows effective against muscular dystrophy
Research
EPFL
A new study published in Science Translational Medicine by EPFL professor Johan Auwerx and scientists from EPFL start-up Amazentis highlights the effectiveness of mitophagy-stimulating molecule Urolithin A in mice to cure a disease similar to Duchenne Muscular Dystrophy. And points to a possible treatment for affected people.
Insight into tumour samples
Research
ETH Zurich
Bernd Bodenmiller  studies the mechanisms of cancer development. The quantitative biologist uses 3D analysis and virtual reality to detect groups of cells that break away from tumours.  
Animal experiments still play a key role
Politics
ETH Zurich
Without animal experiments there would be no COVID-19 vaccine: animal testing is essential for medical research. A ban on testing – even a gradual phase-out – would be extremely damaging for research policy, writes Detlef Günther.
Cancer: a new killer lymphocyte enters the ring
Research
EPFL
A team from EPFL and the Swiss Cancer Center Léman has discovered that CD4 T lymphocytes, which usually play a supporting role in fighting cancer cells, also have the power to destroy them. 
Page 35 of 36